Bachelez, HervéHervéBachelezChoon, Siew-EngSiew-EngChoonMarrakchi, SlaheddineSlaheddineMarrakchiBurden, A DavidA DavidBurdenTSEN-FANG TSAIMorita, AkimichiAkimichiMoritaNavarini, Alexander AAlexander ANavariniZheng, MinMinZhenget al.,et al.2022-09-202022-09-2020210028-4793https://scholars.lib.ntu.edu.tw/handle/123456789/621255Generalized pustular psoriasis (GPP) is a rare, life-threatening, inflammatory skin disease characterized by widespread eruption of sterile pustules. Interleukin-36 signaling is involved in the pathogenesis of this disorder. Spesolimab, a humanized anti-interleukin-36 receptor monoclonal antibody, is being studied for the treatment of GPP flares.enJAPANESE PATIENTS; PLAQUE PSORIASIS; MUTATIONS; PROFILES; SYMPTOMS; EFFICACY; SAFETY[SDGs]SDG3Trial of Spesolimab for Generalized Pustular Psoriasisjournal article10.1056/NEJMoa2111563349367392-s2.0-85122106967WOS:000732866100011https://api.elsevier.com/content/abstract/scopus_id/85122106967